However, it is yet to be clarified in Alzheimer’s disease brains whether and when this down-regulation occurs in response to amyloid-β and tau depositions, which are core pathological processes in the disease etiology. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.